Figure 2. Cutaneous improvement after treatment with tofacitinib.
Improvement in Skin Disease with Treatment at Baseline, 4 weeks and 12 weeks in study subjects enrolled in the study.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.